Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

The Value of Chromosome Analysis to Interrogate Variants in DNMT3B Causing Immunodeficiency, Centromeric Instability, and Facial Anomaly Syndrome Type I (ICF1).

Kellner ES, Rathbun PA, Marshall GS, Tolusso LK, Smolarek TA, Sun M, Chandra S, Bleesing J, Marsh RA.

J Clin Immunol. 2019 Nov 4. doi: 10.1007/s10875-019-00704-6. [Epub ahead of print] No abstract available.

PMID:
31686314
2.

Algorithm-Driven Electronic Health Record Notification Enhances the Detection of Turner Syndrome.

Alexandrou E, Cabrera-Salcedo C, Labilloy G, Tyzinski L, Smolarek TA, Andrew M, Huang Y, Backeljauw P, Dauber A.

J Pediatr. 2019 Oct 18. pii: S0022-3476(19)31159-X. doi: 10.1016/j.jpeds.2019.09.023. [Epub ahead of print]

PMID:
31635814
3.

Neonatal Lung Disease Associated with TBX4 Mutations.

Suhrie K, Pajor NM, Ahlfeld SK, Dawson DB, Dufendach KR, Kitzmiller JA, Leino D, Lombardo RC, Smolarek TA, Rathbun PA, Whitsett JA, Towe C, Wikenheiser-Brokamp KA.

J Pediatr. 2019 Mar;206:286-292.e1. doi: 10.1016/j.jpeds.2018.10.018. Epub 2018 Nov 7.

PMID:
30413314
4.

SH2B3 aberrations enriched in iAMP21 B lymphoblastic leukemia.

Baughn LB, Meredith MM, Oseth L, Smolarek TA, Hirsch B.

Cancer Genet. 2018 Oct;226-227:30-35. doi: 10.1016/j.cancergen.2018.05.004. Epub 2018 Jun 8.

PMID:
30005852
5.

Analysis of copy number variants in 11 pairs of monozygotic twins with neurofibromatosis type 1.

Sites ER, Smolarek TA, Martin LJ, Viskochil DH, Stevenson DA, Ullrich NJ, Messiaen LM, Schorry EK.

Am J Med Genet A. 2017 Mar;173(3):647-653. doi: 10.1002/ajmg.a.38058. Epub 2016 Nov 14.

PMID:
27862945
6.

Copy number variation as a genetic basis for heterotaxy and heterotaxy-spectrum congenital heart defects.

Cowan JR, Tariq M, Shaw C, Rao M, Belmont JW, Lalani SR, Smolarek TA, Ware SM.

Philos Trans R Soc Lond B Biol Sci. 2016 Dec 19;371(1710). pii: 20150406.

7.

Nonclinical Evaluation of PF-06438179: A Potential Biosimilar to Remicade® (Infliximab).

Derzi M, Johnson TR, Shoieb AM, Conlon HD, Sharpe P, Saati A, Koob S, Bolt MW, Lorello LG, McNally J, Kirchhoff CF, Smolarek TA, Leach MW.

Adv Ther. 2016 Nov;33(11):1964-1982. Epub 2016 Sep 1.

8.

Undifferentiated myxoid lipoblastoma with PLAG1-HAS2 fusion in an infant; morphologically mimicking primitive myxoid mesenchymal tumor of infancy (PMMTI)--diagnostic importance of cytogenetic and molecular testing and literature review.

Warren M, Turpin BK, Mark M, Smolarek TA, Li X.

Cancer Genet. 2016 Jan-Feb;209(1-2):21-9. doi: 10.1016/j.cancergen.2015.11.004. Epub 2015 Nov 18. Review.

PMID:
26701195
9.

Rationale for the Cytogenomics of Cardiovascular Malformations Consortium: A Phenotype Intensive Registry Based Approach.

Hinton RB, McBride KL, Bleyl SB, Bowles NE, Border WL, Garg V, Smolarek TA, Lalani SR, Ware SM.

J Cardiovasc Dev Dis. 2015 Apr 29;2(2):76-92. doi: 10.3390/jcdd2020076.

10.

Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray study.

Baughn LB, Biegel JA, South ST, Smolarek TA, Volkert S, Carroll AJ, Heerema NA, Rabin KR, Zweidler-McKay PA, Loh M, Hirsch B.

Cancer Genet. 2015 Jan-Feb;208(1-2):1-18. doi: 10.1016/j.cancergen.2014.11.003. Epub 2014 Nov 21.

11.

Comparative nonclinical assessments of the proposed biosimilar PF-05280014 and trastuzumab (Herceptin(®)).

Hurst S, Ryan AM, Ng CK, McNally JM, Lorello LG, Finch GL, Leach MW, Ploch SA, Fohey JA, Smolarek TA.

BioDrugs. 2014 Oct;28(5):451-9. doi: 10.1007/s40259-014-0103-4.

12.

Further Evidence of Contrasting Phenotypes Caused by Reciprocal Deletions and Duplications: Duplication of NSD1 Causes Growth Retardation and Microcephaly.

Rosenfeld JA, Kim KH, Angle B, Troxell R, Gorski JL, Westemeyer M, Frydman M, Senturias Y, Earl D, Torchia B, Schultz RA, Ellison JW, Tsuchiya K, Zimmerman S, Smolarek TA, Ballif BC, Shaffer LG.

Mol Syndromol. 2013 Jan;3(6):247-54. doi: 10.1159/000345578. Epub 2013 Jan 5.

13.

Regions of homozygosity identified by SNP microarray analysis aid in the diagnosis of autosomal recessive disease and incidentally detect parental blood relationships.

Sund KL, Zimmerman SL, Thomas C, Mitchell AL, Prada CE, Grote L, Bao L, Martin LJ, Smolarek TA.

Genet Med. 2013 Jan;15(1):70-8. doi: 10.1038/gim.2012.94. Epub 2012 Aug 2.

PMID:
22858719
14.

Assessment of minimal residual disease in ewing sarcoma.

Wagner LM, Smolarek TA, Sumegi J, Marmer D.

Sarcoma. 2012;2012:780129. doi: 10.1155/2012/780129. Epub 2012 Mar 12.

15.

Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.

Mehta PA, Harris RE, Davies SM, Kim MO, Mueller R, Lampkin B, Mo J, Myers K, Smolarek TA.

Cancer Genet Cytogenet. 2010 Dec;203(2):180-6. doi: 10.1016/j.cancergencyto.2010.07.127.

PMID:
21156231
16.

Redefined genomic architecture in 15q24 directed by patient deletion/duplication breakpoint mapping.

El-Hattab AW, Smolarek TA, Walker ME, Schorry EK, Immken LL, Patel G, Abbott MA, Lanpher BC, Ou Z, Kang SH, Patel A, Scaglia F, Lupski JR, Cheung SW, Stankiewicz P.

Hum Genet. 2009 Oct;126(4):589-602. doi: 10.1007/s00439-009-0706-x. Epub 2009 Jun 26.

17.

Pharmacokinetics, metabolism, and excretion of torcetrapib, a cholesteryl ester transfer protein inhibitor, in humans.

Dalvie D, Chen W, Zhang C, Vaz AD, Smolarek TA, Cox LM, Lin J, Obach RS.

Drug Metab Dispos. 2008 Nov;36(11):2185-98. doi: 10.1124/dmd.108.023176. Epub 2008 Aug 11.

PMID:
18694908
18.

A new case of de novo 11q duplication in a patient with normal development and intelligence and review of the literature.

Zarate YA, Kogan JM, Schorry EK, Smolarek TA, Hopkin RJ.

Am J Med Genet A. 2007 Feb 1;143A(3):265-70. Review.

PMID:
17219392
19.

Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1.

Chen C, Mireles RJ, Campbell SD, Lin J, Mills JB, Xu JJ, Smolarek TA.

Drug Metab Dispos. 2005 Apr;33(4):537-46. Epub 2004 Dec 22.

PMID:
15616150
20.

The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function.

Aweeka F, Jayesekara D, Horton M, Swan S, Lambrecht L, Wilner KD, Sherwood J, Anziano RJ, Smolarek TA, Turncliff RZ.

Br J Clin Pharmacol. 2000;49 Suppl 1:27S-33S.

21.

The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function.

Everson G, Lasseter KC, Anderson KE, Bauer LA, Carithens RL Jr, Wilner KD, Johnson A, Anziano RJ, Smolarek TA, Turncliff RZ.

Br J Clin Pharmacol. 2000;49 Suppl 1:21S-26S.

22.

Single- and multiple-dose pharmacokinetics of ziprasidone in healthy young and elderly volunteers.

Wilner KD, Tensfeldt TG, Baris B, Smolarek TA, Turncliff RZ, Colburn WA, Hansen RA.

Br J Clin Pharmacol. 2000;49 Suppl 1:15S-20S.

23.

Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774: dynamics of receptor inhibition in situ and antitumor effects in athymic mice.

Pollack VA, Savage DM, Baker DA, Tsaparikos KE, Sloan DE, Moyer JD, Barbacci EG, Pustilnik LR, Smolarek TA, Davis JA, Vaidya MP, Arnold LD, Doty JL, Iwata KK, Morin MJ.

J Pharmacol Exp Ther. 1999 Nov;291(2):739-48.

PMID:
10525095
24.

Cytogenetic analyses of 85 testicular germ cell tumors: comparison of postchemotherapy and untreated tumors.

Smolarek TA, Blough RI, Foster RS, Ulbright TM, Palmer CG, Heerema NA.

Cancer Genet Cytogenet. 1999 Jan 1;108(1):57-69.

PMID:
9973926
25.

Characterization of multiple 12p rearrangements in testicular germ cell tumor cell line 833K and its subclone 64CP by chromosome microdissection.

Blough RI, Vance GH, Henegariu O, Smolarek TA, Sledge GW Jr, Heerema NA.

Cancer Genet Cytogenet. 1998 Oct 1;106(1):24-9.

PMID:
9772905
26.

Interphase chromosome painting of paraffin-embedded tissue in the differential diagnosis of possible germ cell tumors.

Blough RI, Heerema NA, Ulbright TM, Smolarek TA, Roth LM, Einhorn LH.

Mod Pathol. 1998 Jul;11(7):634-41.

PMID:
9688184
27.
28.

Cloning of a breakpoint cluster region on chromosome 14 in uterine leiomyoma.

Bhugra B, Smolarek TA, Lynch RA, Meloni AM, Sandberg AA, Deaven L, Menon AG.

Cancer Lett. 1998 Apr 24;126(2):119-26.

PMID:
9585056
29.

DNA sequence, chromosomal localization, and tissue expression of the mouse proteasome subunit lmp10 (Psmb10) gene.

Cruz M, Elenich LA, Smolarek TA, Menon AG, Monaco JJ.

Genomics. 1997 Nov 1;45(3):618-22.

PMID:
9367687
30.
31.

Identification of multiple chromosome 12 abnormalities in human testicular germ cell tumors by two-color fluorescence in situ hybridization (FISH).

Smolarek TA, Blough RI, Foster RS, Ulbright TM, Palmer CG, Heerema NA.

Genes Chromosomes Cancer. 1995 Dec;14(4):252-8.

PMID:
8605113
32.

High selectivity of polyclonal antibodies against DNA modified by diastereomeric benzo[c]phenanthrene-3,4-diol-1,2-epoxides.

Butch ER, Lau HH, Shaw KL, Smolarek TA, Schmerold I, Anderson JN, Baird WM, Yagi H, Jerina DM.

Carcinogenesis. 1992 May;13(5):895-9.

PMID:
1587005
33.

Metabolism and cytotoxicity of acetaminophen in hepatocyte cultures from rat, rabbit, dog, and monkey.

Smolarek TA, Higgins CV, Amacher DE.

Drug Metab Dispos. 1990 Sep-Oct;18(5):659-63.

PMID:
1981716
34.

Metabolism and DNA adduct formation of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in fish cell lines in culture.

Smolarek TA, Morgan SL, Moynihan CG, Lee H, Harvey RG, Baird WM.

Carcinogenesis. 1987 Oct;8(10):1501-9.

PMID:
3115618
35.
38.

Benz[a]anthracene-induced alterations in the metabolic activation of benzo[a]pyrene by hamster embryo cell cultures.

Smolarek TA, Moynihan CG, Salmon CP, Baird WM.

Cancer Lett. 1986 Mar;30(3):243-9.

PMID:
3754483
40.

7,12-Dimethylbenz[a]anthracene-DNA adduct formation in Wistar rat and Syrian hamster embryo cell cultures.

Sebti SM, Smolarek TA, Salmon CP, Baird WM.

Chem Biol Interact. 1985 Dec 17;56(1):1-12.

PMID:
3935336
41.

Supplemental Content

Loading ...
Support Center